Swallowing dysfunction in Wilson's disease: A scintigraphic study

Neurogastroenterology and Motility

Volumn 20, Issue 4, 2008, Pages 285-290

  Da Silva Junior F P ^a   Carrasco, A E A B ^a   Da Silva Mendes, A M ^b   Lopes, A J T ^b   Nobre E Souza, M A ^a   De Bruin, V M S ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Institute of Cancer   (Brazil)

Author keywords

Aspiration pneumonia; Dysphagia; Morbidity; Scintigraphy; Swallowing; Wilson's disease

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SCINTIGRAPHY; SWALLOWING; WILSON DISEASE;

ADULT; DEGLUTITION DISORDERS; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING;

EID: 41149175546     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.01036.x     Document Type: Article

References (25)

1. Ferenci P. Wilson's disease. Clin Liver Dis 1998 2 : 31 49.
2. Frydman M. Genetic aspects of Wilson's disease. J Gastroenterol Hepatol 1990 5 : 483 90.
3. Sternlieb I. Wilson's disease. Clin Liver Dis 2000 4 : 229 39.
4. Cuthbert JA. Wilson's disease. Update of a systemic disorder with protean manifestations. Gastroenterol Clin North Am 1998 27 : 655 81.
5. Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther 2004 19 : 157 65.
6. Oder W, Prayer L, Grimm G et al. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology 1993 43 : 120 4.
7. Van Wassenaer-van Hall HN, van der Heuvel AG, Algra A, Hoogenraad TU, Mali WP. Wilson's disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996 198 : 531 6.
8. Chen MY, Peele VN, Donati D, Otto DJ, Donofrio PD, Gelfand DW. Clinical and videofluoroscopic evaluation of swallowing in 41 patients with neurologic disease. Gastrointest Radiol 1992 17 : 95 8.
9. Johnston BT, Li Q, Castell JA, Castell DO. Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol 1995 90 : 1741 6.
10. Barthel H, Hermann W, Kluge R et al. Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol 2003 24 : 234 8.
11. Roberts EA, Schilsky ML. A practice guideline on Wilson's disease. Hepatology 2003 37 : 1475 92.
12. Hamlet S, Choi J, Zormeier M et al. Normal adult swallowing of liquid and viscous material: scintigraphic data on bolus transit and oropharyngeal residues. Dysphagia 1996 11 : 41 7.
13. Muz J, Mathog RH, Hamlet SL, Davis LP, Kling GA. Objective assessment of swallowing function in head and neck cancer patients. Head Neck 1991 13 : 33 9.
14. Nobre e Souza MA, Dantas RO, de Oliveira RB, Braga FJHN. A scintigraphic study of oropharyngeal swallowing dynamics in Chagas' disease. Neurogastroenterol Motil 2000 12 : 335 41.
15. Miranda ALM, Dantas RO. Esophageal contractions and oropharyngeal and esophageal transits in patients with iron deficiency anemia. Am J Gastroenterol 2003 98 : 1000 4.
16. Perkin GD, Murray-Lyon I. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry 1998 65 : 291 300.
17. Gulyas AE, Salazar-Grueso EF. Pharyngeal dysmotility in a patient with Wilson's disease. Dysphagia 1988 2 : 230 4.
18. Haggstrom G, Hirschowitz BI. Disordered esophageal motility in Wilson's disease. J Clin Gastroenterol 1980 2 : 273 5.
19. Monte FS, da Silva-Júnior FP, Braga-Neto P, Nobre e Souza MA, de Bruin VMS. Swallowing abnormalities and dyskinesia in Parkinson's disease. Mov Disord 2005 20 : 457 62.
20. Holt S, Miron SD, Diaz MC, Shields R, Ingrahan D, Bellon EM. Scintigraphic measurement of oropharyngeal transit in man. Dig Dis Sci 1990 35 : 1198 204.
21. Czlonkowska A, Tarnacka B, Litwin T, Gadja J, Rodo M. Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period. J Neurol 2005 252 : 698 703.
22. Park RH, McCabe P, Fell GS, Russel RL. Wilson's disease in Scotland. Gut 1991 32 : 1541 5.
23. Brewer GJ. Penicillamine should not be used as initial therapy in Wilson's disease. Mov Disord 1999 14 : 551 4.
24. Walshe JM. Penicillamine: the treatment of first choice for patients with Wilson's disease. Mov Disord 1999 14 : 545 50.
25. Walshe JM, Yealland M. Chelation treatment of neurological Wilson's disease. QJM 1993 86 : 197 204.